Showing results (31-40 of 61) with videos related to
Sort By:
Pageof 7
Cancer Medicine|March 18, 2021
Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real-world evidence from the medicare populationRavi K Goyal, Saurabh P Nagar, Shaum M Kabadi, et al.Plos Neglected Tropical Diseases|December 5, 2014
HSP70 domain II of Mycobacterium tuberculosis modulates immune response and protective potential of F1 and LcrV antigens of Yersinia pestis in a mouse modelLalit Batra, Shailendra K Verma, Durgesh P Nagar, et al.Leukemia & Lymphoma|October 3, 2018
Adverse events, resource use, and economic burden associated with mantle cell lymphoma: a real-world assessment of privately insured patients in the United StatesRavi K Goyal, Saurabh P Nagar, Shaum M Kabadi, et al.Human & Experimental Toxicology|January 13, 2017
In vivo protection studies of bis-quaternary 2-(hydroxyimino)- N-(pyridin-3-yl) acetamide derivatives (HNK oximes) against tabun and soman poisoning in Swiss albino miceP Kumar, D Swami, D P Nagar, et al.Clinical Breast Cancer|May 21, 2019
Treatment Patterns and Outcomes Associated With Palbociclib Plus Letrozole for Postmenopausal Women With HR+/HER2- Advanced Breast Cancer Enrolled in an Expanded Access ProgramAdam Brufsky, Debanjali Mitra, Keith L Davis, et al.Journal of Managed Care & Specialty Pharmacy|June 28, 2016
Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care SettingBenjamin Chastek, Stephanie Korrer, Saurabh P Nagar, et al.Diabetes Care|September 23, 2022
Herpes Zoster Incidence and Burden in Adults With Type 2 Diabetes in the U.S.: A Retrospective Database AnalysisJean-Etienne Poirrier, Juliana L Meyers, Saurabh P Nagar, et al.Environmental Toxicology and Pharmacology|February 17, 2020
Pulmonary protective efficacy of S-2[2-aminoethylamino] ethyl phenyl sulphide (DRDE-07) and its analogues against sulfur mustard induced toxicity in miceA K Soni, A S B Bhaskar, U Pathak, et al.Respiratory Research|June 2, 2012
Observational study of the outcomes and costs of initiating maintenance therapies in patients with moderate exacerbations of COPDAnand A Dalal, Manan B Shah, Anna O D'Souza, et al.Journal of Managed Care & Specialty Pharmacy|January 7, 2015
Health care costs among renal cancer patients using pazopanib and sunitinibRyan N Hansen, Michelle D Hackshaw, Saurabh P Nagar, et al.Pageof 7